Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...
Atrial fibrillation (AF) is the most common abnormal heart rhythm affecting 6 million people in the USA and can cause strokes and heart failure. Conventional treatments are successful but may need to ...
Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...
Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
DEAR DR. ROACH: I’m a 75-year-old woman who, for at least 10 years now, has been experiencing a rapid heart rate. My blood pressure, however, remains normal. In fact, doctors are usually surprised at ...
The study, recently published in the Journal of the American Heart Association, adds to a body of research dispelling the ...
New research shows how alcohol affects heart health in women on hormone therapy. Find out the shocking connection and what ...
UVA Health scientists have developed a new, noninvasive way to assess heart health using MRI technology. A few scientists spearheading this latest development say it could lead to better outcomes for ...
Cardiac ablation has emerged as a transformative medical procedure for patients struggling with irregular heart rhythms particularly atrial fibrillation AFib By targeting and eliminating problematic a ...
Queen Sonja of Norway was admitted to the hospital on Jan. 11 following a flare-up of her atrial fibrillation while skiing.
Targeting these processes may offer new avenues for treatment ... play a role in the development of irregular heart rhythms. Treating atrial fibrillation Current treatments for atrial fibrillation ...